Relmada Therapeutics (RLMD) Insider Trading & Ownership $2.88 +0.03 (+1.05%) (As of 10:31 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Relmada Therapeutics (NASDAQ:RLMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.00%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$779,959.33Number OfInsiders Selling(Last 12 Months)0 Get RLMD Insider Trade Alerts Want to know when executives and insiders are buying or selling Relmada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RLMD Insider Buying and Selling by Quarter Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Relmada Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/11/2024Maged ShenoudaCFOBuy24,120$2.95$71,154.00 9/11/2024Sergio TraversaCEOBuy51,407$2.99$153,706.93 9/9/2024Charles J CasamentoDirectorBuy13,000$2.56$33,280.00 9/9/2024Maged ShenoudaCFOBuy8,194$2.55$20,894.70 9/9/2024Sergio TraversaCEOBuy55,579$2.71$150,619.09 1/31/2024Maged ShenoudaCFOBuy6,875$4.06$27,912.50 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/31/2024Sergio TraversaCEOBuy27,460$4.00$109,840.00 1/30/2024Chuck EnceInsiderBuy14,500$3.87$56,115.00 1/29/2024Maged ShenoudaCFOBuy10,800$3.65$39,420.00 1/29/2024Sergio TraversaCEOBuy31,541$3.71$117,017.11 (Data available from 1/1/2013 forward) RLMD Insider Trading Activity - Frequently Asked Questions Who is on Relmada Therapeutics's Insider Roster? The list of insiders at Relmada Therapeutics includes Cedric O'gorman, Charles J Casamento, Chuck Ence, Maged Shenouda, Paul Edward Kelly, and Sergio Traversa. Learn more on insiders at RLMD. What percentage of Relmada Therapeutics stock is owned by insiders? 18.00% of Relmada Therapeutics stock is owned by insiders. Learn more on RLMD's insider holdings. Which Relmada Therapeutics insiders have been buying company stock? The following insiders have purchased RLMD shares in the last 24 months: Cedric O'gorman ($31,800.00), Charles J Casamento ($33,280.00), Chuck Ence ($56,115.00), Maged Shenouda ($159,381.20), and Sergio Traversa ($647,208.13). How much insider buying is happening at Relmada Therapeutics? Insiders have purchased a total of 308,726 RLMD shares in the last 24 months for a total of $927,784.33 bought. Relmada Therapeutics Key ExecutivesDr. Sergio Traversa M.B.A. (Age 64)Pharm.D., CEO & Director Compensation: $1.79MMr. Maged S. Shenouda M.B.A. (Age 60)R.Ph., Chief Financial Officer Compensation: $1.01MMr. Charles S. Ence CPA (Age 59)M.B.A., Chief Accounting & Compliance Officer Compensation: $995.03kDr. Paolo Manfredi M.D. (Age 62)Ph.D., Chief Scientific Officer Ms. Gina DiGuglielmoVP & Head of Clinical OperationsDr. Marco Pappagallo M.D. (Age 65)Chief Clinical Officer Mr. John HixonHead of CommercialDr. Andrew CutlerSenior Clinical Development AdvisorDr. Richard M. Mangano (Age 74)Consultant More Insider Trading Tools from MarketBeat Related Companies Neoleukin Therapeutics Insider Trades Q32 Bio Insider Trades biote Insider Trades Jasper Therapeutics Insider Trades Design Therapeutics Insider Trades Cryoport Insider Trades Aclaris Therapeutics Insider Trades COMPASS Pathways Insider Trades Sage Therapeutics Insider Trades Kodiak Sciences Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:RLMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relmada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relmada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
